Leukemia Research
Volume 33, Issue 11 , Pages 1574-1577, November 2009

Aleukemic bcr-abl positive granulocytic sarcoma

  • Jew-Win Kuan

      Affiliations

    • Hematology Department, Ampang Hospital, Jalan Mewah Utara, Pandan Mewah, 68000 Ampang, Selangor, Malaysia
    • Corresponding Author InformationCorresponding author. Tel.: +60 198593011; fax: +60 362501864.
  • ,
  • Rajadurai Pathmanathan

      Affiliations

    • Pathology Department, Sime Darby Medical Centre Subang Jaya, 1, Jalan SS 12/1A, 47500 Subang Jaya, Selangor, Malaysia
  • ,
  • Kian-Meng Chang

      Affiliations

    • Hematology Department, Ampang Hospital, Jalan Mewah Utara, Pandan Mewah, 68000 Ampang, Selangor, Malaysia
  • ,
  • Sen-Moi Tan

      Affiliations

    • Hematology Department, Ampang Hospital, Jalan Mewah Utara, Pandan Mewah, 68000 Ampang, Selangor, Malaysia

Received 27 October 2008; received in revised form 13 January 2009; accepted 15 January 2009. published online 07 March 2011.

Abstract 

Granulocytic sarcoma (GS) can occur de novo or in association with intramedullary myeloid disorders. With the advent of sophisticated molecular detection techniques to detect diagnostic genes such as bcr-abl, PML-RARA and CBFB/MYH11 in bone marrow or peripheral blood, many cases of the so called ‘primary’ GS are questionable. We report a case of primary GS where the tumor mass bcr-abl translocation was demonstrated by fluorescent in situ hybridization in which there was no evidence of chronic myeloid leukemia (CML). This is an important finding as it highlights the possibility that CML may present as a sole extramedullary form, and illustrates potential treatment by tyrosine kinase inhibitor.

Keywords: Granulocytic sarcoma, Bcr-abl, CML

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(09)00023-X

doi:10.1016/j.leukres.2009.01.016

Leukemia Research
Volume 33, Issue 11 , Pages 1574-1577, November 2009